Clinical Trial Update: A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 trial evaluating BGB-C354 alone and in combination with tislelizumab in participants with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BGB-C354
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeOne Medicines | Conditions: Advanced Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING